Literature DB >> 16786469

[Avoidance of intermittent T-wave oversensing with device programming].

M Wieczorek1, R Hoeltgen, I Djajadisastra.   

Abstract

We report the case of a 35-year-old man who was suffering from severe heart failure due to cardiomyopathy. He underwent heart transplantation years ago and developed complex ventricular arrhythmias in the following months in combination with recurrent episodes of syncope due to hypertrophic non-obstructive cardiomyopathy in the transplanted heart, so a dual chamber ICD was implanted. Months later repetitive episodes of intermittent T-wave oversensing with consecutive activation of the ICD could be observed. Surgical revision of the electrode was performed and the patient was closely followed up. One year later, further episodes of T-wave oversensing led to multiple inappropriate IDC-shocks. A very short AV-conduction time was programmed to allow ventricular capture whenever possible, because T-wave oversense after ventricular capture would be annotated as single ventricular ectopy not resulting in antitachycardia pacing. As a consequence, the patient was free from inappropriate ICD-shocks, but showed several shorter episodes of T-wave oversensing. They were all initiated by atrial activity that was seen in the refractory period, thus leading to a loss of AV synchrony. Programming a very short post ventricular atrial refractory period (PVARP) in addition to a short AV-delay led to the complete disappearance of T-wave oversensing in this patient. During a 9-month follow-up, no further tachycardia episodes were detected by the device.

Entities:  

Mesh:

Year:  2006        PMID: 16786469     DOI: 10.1007/s00399-006-0481-5

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN: 0938-7412


  8 in total

1.  Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion.

Authors:  F Duru; U Bauersfeld; R Candinas
Journal:  Europace       Date:  2001-01       Impact factor: 5.214

2.  Inappropriate discharges from an intravenous implantable cardioverter defibrillator due to T-wave oversensing.

Authors:  T Washizuka; M Chinushi; H Kasai; H Watanabe; M Tagawa; Y Hosaka; A Abe; Y Aizawa
Journal:  Jpn Circ J       Date:  2001-07

3.  QT dependent T wave sensing.

Authors:  A Böhm; A Pintér; I Préda
Journal:  Pacing Clin Electrophysiol       Date:  1998-07       Impact factor: 1.976

4.  Ventricular oversensing: a study of 101 patients implanted with dual chamber defibrillators and two different lead systems.

Authors:  Slawomir Weretka; Jochen Michaelsen; Ruediger Becker; Christoph A Karle; Frederik Voss; Thomas Hilbel; Brigitte R Osswald; Malte L Bahner; Julia C Senges; Wolfgang Kuebler; Wolfgang Schoels
Journal:  Pacing Clin Electrophysiol       Date:  2003-01       Impact factor: 1.976

5.  Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemia.

Authors:  A Krishen; R K Shepard; J A Leffler; M A Wood; K A Ellenbogen
Journal:  Pacing Clin Electrophysiol       Date:  2001-11       Impact factor: 1.976

6.  Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery.

Authors:  Rainer Schimpf; Christian Wolpert; Francesca Bianchi; Carla Giustetto; Florenzo Gaita; Urs Bauersfeld; Martin Borggrefe
Journal:  J Cardiovasc Electrophysiol       Date:  2003-12

7.  Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks.

Authors:  Ashok K Koul; Seth Keller; Jude F Clancy; Rachel Lampert; William P Batsford; Lynda E Rosenfeld
Journal:  Pacing Clin Electrophysiol       Date:  2004-05       Impact factor: 1.976

8.  Problems in managing patients with long QT syndrome and implantable cardioverter defibrillators: a report of two cases.

Authors:  G Y Perry; E M Kosar
Journal:  Pacing Clin Electrophysiol       Date:  1996-05       Impact factor: 1.976

  8 in total
  1 in total

1.  [Progression of heart failure during cardiac resynchronization therapy: what is the cause?].

Authors:  C W Israel; M Britten
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.